Clinical trials
Active, not recruiting Phase 2 Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 13 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Regeneron Pharmaceuticals | 3 |
| Amgen | 2 |
| Kailera | 2 |
| Novo Nordisk A/S | 2 |
| Pfizer | 2 |
| Shanghai Minwei Biotechnology Co., Ltd | 2 |
| Antag Therapeutics | 1 |
| Aphaia Pharma US LLC | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 41 |
| Overweight | 19 |
| Diabetes Mellitus, Type 2 | 5 |
| Body Weight | 3 |
| Diabetes Mellitus | 2 |
| Endocrine System Diseases | 2 |
| Nutrition Disorders | 2 |
| Overnutrition | 2 |
| Weight Loss | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.